"At the start of this year, a new 7.2mg dose was approved, with people losing an average of 18.7 per cent of their starting body weight." However, the Wegovy pill is the first of multiple GLP-1 pills which are likely to hit the market in the next few years
PLoS ONE 9 (12), e112726 (2014) Borlinghaus, J., Albrecht, F., Gruhlke, M.C., Nwachukwu, I.D., Slusarenko, A.J.: Allicin: chemistry and biological properties
When BMI isnt the right tool BMI is a useful screening number, but it has known limits
"Hair loss is a patient-valued outcome," lead researcher Yong Chen wrote, adding that it can affect "self-esteem, quality of life, and adherence to treatment." For many, the benefits vastly outweigh the drawbacks, but researchers said the findings should help patients understand the potential trade-offs before startingor deciding whether to continuethe highly popular medication.
Specificity of Drosophila cytonemes for distinct signaling pathways
For individuals considering or currently receiving Wegovy treatment, sharing experiences and receiving professional guidance are essential